QNCX
Quince Therapeutics, Inc.
29.20$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -86.8% | +10.0% | +95.5% | -81.4% | +100.0% | +9.4% | +2.9% | +8.3% | -7.7% | +13.9% | – | |
| – | -18.4% | +17.3% | -4.0% | -8.1% | +0.1% | +23.2% | -8.2% | -1.4% | -5.1% | +8.0% | +840.4% | – | |
| – | – | -422.0% | – | – | – | +8.2% | -191.3% | – | +6,327.8% | -215.9% | – | – | |
| – | – | +62.5% | +0.0% | +17.9% | +189.1% | +11.3% | -14.9% | -41.3% | -94.6% | +0.0% | -100.0% | – | |
| – | – | – | -155.8% | – | +52.9% | +0.3% | -44.6% | -129.5% | – | – | -33.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | +470.0% | +233.3% | -81.6% | -14,385.7% | -100.0% | – | +16,465.5% | -90.5% | +47.8% | +364.3% | +1,053.6% | – | |
| – | – | – | -1,412.3% | – | – | -55.9% | +480.8% | -214.6% | – | – | +691.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.